Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early vs Routine Caffeine in Preterm Neonates
NCT01783561Phase 4Completed
- Sponsor
- Sharp HealthCare
- Start
- Oct 2013
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of caffeine in apnea of prematurity (AOP) (2 arms), sponsored by Sharp HealthCare. Primary endpoint: Need for endotracheal intubation at 12 hours. Started Oct 2013; status: completed.
02
Drugs
caffeine
03
Conditions
apnea of prematurity (AOP)
Beyond the preview
Go deeper on NCT01783561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01783561.